Skip to main content
logo
Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China flag China · Delayed Price · Currency is CNY
45.09
+0.49 (1.10%)
At close: Feb 13, 2026

SHA:688273 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
4,4102,2873,3523,260--
Market Cap Growth
103.55%-31.77%2.81%---
Enterprise Value
3,6431,4202,2812,045--
Last Close Price
45.0922.8431.0629.81--
PE Ratio
43.4622.5137.3226.79--
Forward PE
-12.4321.56---
PS Ratio
10.075.399.838.65--
PB Ratio
3.161.702.442.38--
P/TBV Ratio
3.451.882.552.45--
P/FCF Ratio
--54.2745.02--
P/OCF Ratio
35.1518.6724.4825.74--
EV/Sales Ratio
8.323.346.695.43--
EV/EBITDA Ratio
28.0811.5028.7417.74--
EV/EBIT Ratio
36.1713.5334.5019.56--
EV/FCF Ratio
-376.28-36.9328.25--
Debt / Equity Ratio
0.010.010.010.010.020.03
Debt / EBITDA Ratio
0.130.080.100.080.050.05
Debt / FCF Ratio
--0.140.130.050.07
Net Debt / Equity Ratio
-0.57-0.66-0.79-0.88-0.71-0.58
Net Debt / EBITDA Ratio
-6.44-7.16-13.72-10.46-2.17-1.04
Net Debt / FCF Ratio
82.00122.86-17.63-16.66-1.99-1.35
Asset Turnover
0.290.280.220.380.831.11
Inventory Turnover
2.111.861.602.223.103.46
Quick Ratio
8.075.618.3310.072.832.05
Current Ratio
8.826.158.8010.693.412.40
Return on Equity (ROE)
7.59%8.00%6.74%14.84%38.60%59.95%
Return on Assets (ROA)
4.12%4.26%2.71%6.53%17.26%26.77%
Return on Invested Capital (ROIC)
15.23%24.38%26.78%68.67%99.19%129.68%
Return on Capital Employed (ROCE)
7.00%7.60%4.70%7.50%29.20%51.80%
Earnings Yield
2.30%4.44%2.68%3.73%--
FCF Yield
-0.22%-0.32%1.84%2.22%--
Dividend Yield
1.33%3.50%1.93%4.36%--
Payout Ratio
61.95%97.36%91.54%41.09%0.03%44.39%
Buyback Yield / Dilution
0.98%1.46%-20.00%-11.11%-0.00%-
Total Shareholder Return
2.33%4.96%-18.07%-6.75%-0.00%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.